Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2012

Open Access 01.12.2012 | Research

The effect of laparoscopic surgery in stage II and III right-sided colon cancer: a retrospective study

verfasst von: Bong-Hyeon Kye, Jun-Gi Kim, Hyeon-Min Cho, Jung Hwan Lee, Hyung-Jin Kim, Young-Jin Suh, Chung-Soo Chun

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

This retrospective study compared the clinicopathological results among three groups divided by time sequence to evaluate the impact of introducing laparoscopic surgery on long-term oncological outcomes for right-sided colon cancer.

Methods

From April 1986 to December 2006, 200 patients who underwent elective surgery with stage II and III right-sided colon cancer were analyzed. The period for group I referred back to the time when laparoscopic approach had not yet been introduced. The period for group II was designated as the time when first laparoscopic approach for right colectomy was carried out until we overcame its learning curve. The period for group III was the period after overcoming this learning curve.

Results

When groups I and II, and groups II and III were compared, overall survival (OS) did not differ significantly whereas disease-free survival (DFS) in groups I and III were statistically higher than in group II (P = 0.042 and P = 0.050). In group III, laparoscopic surgery had a tendency to provide better long-term OS ( P = 0.2036) and DFS ( P = 0.2356) than open surgery. Also, the incidence of local recurrence in group III (2.6%) was significantly lower than that in groups II (7.4%) and I (12.1%) ( P = 0.013).

Conclusions

Institutions should standardize their techniques and then provide fellowship training for newcomers of laparoscopic colon cancer surgery. This technique once mastered will become the gold standard approach to colon surgery as it is both safe and feasible considering the oncological and technical aspects.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-10-89) contains supplementary material, which is available to authorized users.

Competing interests

The manuscript is an original work and has not been submitted or is under consideration for publication in another journal. The study complies with current ethical consideration. We also confirm that all the listed authors have participated actively in the study, and have seen and approved the submitted manuscript. The authors do not have any possible conflicts of interest. No competing financial interests exist.

Authors’ contributions

K and JGK conceived and designed the study; K, C, HJK, L, S, JGK, and C acquired the data; K, C, HJK, L, S, JGK, and C analyzed and interpreted the data; K, HJK, JGK, and C drafted the manuscript; K, C, HJK, JGK, S, L, and C critically revised the manuscript; K, C, HJK, L, S, JGK, and C approved the final manuscript. All authors read and approved the final manuscript.

Background

Colorectal cancer, the second most common cancer in Korea, has been increasing exponentially probably due to Westernized dietary habits. After the first laparoscopic colon resection was reported by Jacobs et al. [1] in 1991 many articles were published about the feasibility of laparoscopic surgery. Then, numerous articles acclaimed laparoscopic surgery for its short-term benefits despite the long operation time. Recently, articles from multicenter trials suggested that long-term outcome of laparoscopic surgery was not inferior to that of open surgery [25]. Although many data are yet to be statistically validated, results tend to show that advantages of laparoscopic surgery outweigh those of open surgery [68]. It is imperative to overcome the learning curve (LC) of laparoscopic surgery but once conquered, laparoscopic surgery appears to be a more desirable procedure with numerous benefits. In our institution, we introduced laparoscopic surgery in 1991 and have performed laparoscopic colon surgery since 1994 to the present. This procedure has now become a standard surgical procedure for colon cancer in our institute and this has led us to observe whether long-term oncological outcome of laparoscopic colon cancer surgery was comparable to that of open surgery. Moreover, we were curious to find out the short- and long-term consequences of the LC.
At our institute we gathered 21 years of data to evaluate the long-term oncological impact of introducing the laparoscopic approach in right-sided colon cancer surgery and to propose whether laparoscopic surgery should replace open surgery in the near future and become the gold standard method in the area of colorectal surgery.

Methods

In total, 218 patients revealing pathologic stage II or III of right-sided colon cancer who underwent curative resection at the Department of Surgery, St. Vincent’s Hospital, The Catholic University of Korea from April 1986 to December 2006 were evaluated retrospectively. Of those, 18 patients who underwent emergency operation for cancer perforation or obstruction were excluded. After obtaining the review board approval from our institute, demographics and tumor stages of 200 patients who underwent elective surgery were identified. For our study, we defined right-sided colon cancer as a confirmed adenocarcinoma arising from the cecum, ascending colon, hepatic flexure colon, or proximal transverse colon. We performed right hemicolectomy (RHC) or extended right hemicolectomy (ERHC) for right-sided colon cancer. In the case of lymph node dissection, high vessel ligation that involved ligating the vessel root of ileocolic artery and mid colic artery in ERHC or ligating the right branch of mid colic artery and the root of ileocolic artery in RHC was referred to as D3. Low vessel ligation that involved ligating the vessel around marginal artery was designated as D2.
We divided our patients into three separate groups according to time sequence. Group I referred back to the time when laparoscopic approach had not yet been introduced. Group II was designated as the time when first laparoscopic approach for right-sided colectomy was carried out until its LC was overcome. Group III was the period after overcoming this LC. For the LC of laparoscopic right-sided colectomy in our institute, we used the CUSUM model for surgical outcomes. For CUSUM charts, the observed score for successful laparoscopic surgery was defined as 0, and the score for conversion, intraoperative complications, postoperative complications, or lymph node retrieval of less than 12 from the acquired specimen from surgery were identified as 1. Also, the mean value of our series (=0.09) was used as the expected score for the CUSUM charts. With the CUSUM analysis, we found that the LC of laparoscopic right-sided colectomy in all TNM stages had been overcome after the 18th laparoscopic right-sided colectomy (Figure 1). Since the introduction of laparoscopic procedure, the same surgical methods were used even during open surgery. Thus when dividing the groups, both open and laparoscopic surgeries were included. Therefore, 58 patients enrolled in group I, 27 patients in group II, and 115 patients in group III. In the period of group II, we defined this period from the very first laparoscopic right-sided colon cancer surgery to the 18th laparoscopic operation, but this includes open surgeries as well in between. By running CUSUM analysis to obtain the LC of laparoscopic right-sided colon cancer for all TNM stages, we found that the LC was 18 cases in order to perform the surgery with a comparable level of efficiency. However, the subjects of this study were only patients with stage II and III right-sided colon cancer, so only 12 out of 18 patients were allocated to group II. Thus, in group II, 15 patients underwent open surgery and 12 patients underwent laparoscopic procedure. In group III, 34 patients underwent open surgery and 81 patients underwent laparoscopic surgery. We had kept the indication of laparoscopic colon cancer surgery for all stages except for the stage T4 cancer with severe invasion to adjacent organ. However during early period, higher costs were required for laparoscopic surgery than open surgery since laparoscopic surgery was not covered by the health insurance system in Korea at that time. For this reason, we discussed laparoscopic surgery in detail with group II patients and its high costs and whether they preferred to receive open or laparoscopic surgery. Therefore, we believe the number of patients who underwent laparoscopic surgery in group II was smaller than those who had open surgery. Since laparoscopic surgery’s benefits started to become recognized and became partially covered by the health insurance system in Korea, the number of cases increased. Still, there are patients with financial issues who cannot afford non-deductable disposable instruments such as Ligasure (Covidien, Mansfield, MA, USA) or Harmonic Scalpel (Ethicon Endo-Surgery, Cincinnati, OH, USA) opting patients to have open surgery. This describes the reason for the number of patients in group III having open surgery. We would like to clarify that with the same indication of laparoscopic or open surgery, it was the patient who decided which operative method to receive, not their disease condition. Hence, the oncological outcome was analyzed in each group. In addition, in groups II and III oncological outcome was compared between open and laparoscopic surgery.
In order to rule out unnecessary bias we needed to observe whether clinicopathological features were evenly distributed in each group. The risk factors that might have been associated with the oncological outcome were age, gender, body mass index (BMI), American Society of Anesthesiologists (ASA) physical status, tumor location, operative approach method, range of lymph node dissection, pathologic stage using UICC system, pathologic T and N status, microscopic differentiation, number of retrieved lymph nodes, whether chemotherapy was performed or not, whether reoperation was carried out or not, and preoperative or postoperative serum carcinoembryonic antigen (CEA) level.
One-way ANOVA for continuous variables and Chi-square test for categorical variables were used for comparing the clinicopathological features among three groups. Continuous variables are expressed as the mean ± standard error. The survival probability analysis was performed using the Kaplan-Meier method. The log-rank test was used to assess the difference of survival between strata. The Cox proportional-hazards regression model with forward selection was used for multivariate analysis with statistical significance accepted at P < 0.05.
The applied statistical software was SPSS® 12.0 (SPSS Inc., Chicago, IL, USA), while CUSUM model was analyzed using Minitab® 14.0 (Minitab Inc., State College, PA, USA).

Results

The patients’ ages ranged from 25 to 87 years, with a mean age of 61.9 ± 12.6 years. A comparison of preoperative and postoperative risk factors among the three groups is shown in Table 1. As time passed, the laparoscopic approach was more frequently applied to right-sided colon cancer surgery. Becoming accustomed to the laparoscopic approach, high vessel ligation with D3 lymph node dissection was more frequently performed (P <0.001). Although longer operation times were needed in groups II and III than in group I, better short-term outcomes in postoperative complication and postoperative recovery were observed in group III than in group I (Table 1).
Table 1
Overview of clinical data in 200 patients who underwent right sided colon cancer surgery
   
Group I ( n  = 58)
Group II ( n  = 27)
Group III ( n  = 115)
P value
Patient characteristic
Age (years)
≤65
38 (66.7%)
16 (59.3%)
52 (45.2%)
 
  
>65
19 (33.3%)
11 (40.7%)
63 (54.8%)
0.007
 
Gender
Male
26 (44.8%)
13 (48.1%)
56 (48.7%)
 
  
Female
32 (55.2%)
14 (51.9%)
59 (51.3%)
0.641
 
ASA
1
41 (70.7%)
13 (48.1%)
64 (55.7%)
 
  
2
15 (25.9%)
13 (48.1%)
46 (40.0%)
 
  
3
2 (3.4%)
1 (3.7%)
5 (4.3%)
0.114
 
BMI (kg/m2)
Mean ± S.D.
20.7 ± 3.9
22.4 ± 2.5
22.4 ± 3.3
0.001
Operative procedure
Operation method
RHC
45 (77.6%)
19 (70.4%)
75 (65.2%)
 
  
ERHC
13 (22.4%)
8 (29.6%)
40 (34.8%)
0.096
 
Approach
Open
58 (100%)
15 (55.6%)
34 (29.6%)
 
  
Lap
-
12 (44.4%)
81 (70.4%)
<0.001
 
Vessel ligation
Low
6 (26.1%)
3 (17.6%)
4 (3.7%)
 
  
High
17 (73.9%)
14 (82.4%)
103 (96.3%)
<0.001
Macroscopic feature
Location
Cecum
12 (20.7%)
11 (40.7%)
17 (14.8%)
 
  
Ascending
25 (43.1%)
9 (33.3%)
57 (49.6%)
 
  
H flexure
20 (34.5%)
7 (25.9%)
23 (20.0%)
 
  
prox T
1 (1.7%)
0
18 (15.7%)
0.097
 
Tumor size
≤6.5
34 (58.6%)
17 (63.0%)
61 (53.5%)
 
  
>6.5
24 (41.4%)
10 (37.0%)
53 (46.5%)
0.467
  
Mean ± S.D.
6.5 ± 2.6
6.6 ± 3.2
6.6 ± 2.7
0966
Microscopic feature
Stage
II
40 (69.0%)
18 (66.7%)
64 (56.1%)
 
  
III
18 (31.0%)
9 (33.3%)
50 (43.9%)
0.090
 
Pathologic T
2
2 (3.4%)
1 (3.7%)
2 (1.8%)
 
  
3
47 (81.0%)
24 (88.9%)
100 (87.7%)
 
  
4
9 (15.5%)
2 (7.4%)
12(10.5%)
0.651
 
Pathologic N
0
36 (62.1%)
18 (66.7%)
64 (56.1%)
 
  
1
15 (25.9%)
5 (18.5%)
31 (27.2%)
 
  
2
7 (12.1%)
4 (14.8%)
19 (16.7%)
0.345
 
Differentiation
Well
21 (36.2%)
16 (59.3%)
17 (14.9%)
 
  
Moderately
19 (32.8%)
6 (22.2%)
85 (74.6%)
 
  
Poorly
11 (19.0%)
3 (11.1%)
9 (7.9%)
 
  
Mucinous
7 (12.1%)
2 (7.4%)
3 (2.6%)
0.685
 
Lymphatic invasion
No
10 (35.7%)
15 (62.5%)
88 (77.2%)
 
  
Yes
18 (64.3%)
9 (37.5%)
26 (22.8%)
<0.001
 
Venous invasion
No
25 (89.3%)
22 (91.7%)
111 (97.4%)
 
  
Yes
3 (10.7%)
2 (8.3%)
3 (2.6%)
0.051
 
Perineural invasion
No
25 (86.2%)
22 (91.7%)
97 (85.1%)
 
  
Yes
4 (13.8%)
2 (8.3%)
17 (14.9%)
0.708
 
Retrieved LN
<12
4 (6.9%)
10 (37.0%)
22 (19.3%)
 
  
≥12
54 (93.1%)
17 (63.0%)
92 (80.7%)
0.103
Additional treatment
Adjuvant CTx
No
15 (26.3%)
1 (3.8%)
17 (14.9%)
 
  
Yes
42 (73.7%)
25 (96.2%)
97 (85.1%)
0.105
Perioperative course
OP time(mins)
Mean ± S.D.
199.5 ± 83.4
308.5 ± 109.9
298.7 ± 86.8
<0.001
 
Intraoperative Cx
No
58 (100%)
26 (96.3%)
111 (96.5%)
 
  
Yes
0
1 (3.7%)
4 (3.5%)
0.189
 
Intraoperative TF (mL)
Mean ± S.D
361.6 ± 636.4
120.4 ± 243.9
83.3 ± 224.8
<0.001
 
Postoperative Cx
No
45 (77.6%)
22 (81.5%)
102 (88.7%)
 
  
Yes
15 (22.4%)
5 (18.5%)
13 (11.3%)
0.052
 
Postoperative TF (mL)
Mean ± S.D
156.9 ± 362.9
129.6 ± 233.8
164.5 ± 250.7
0.850
 
Reoperation
No
56 (96.6%)
26 (96.3%)
114 (99.1%)
 
  
Yes
2 (3.4%)
1 (3.7%)
1 (0.9%)
0.223
 
ICU stay (days)
mean ± S.D
4.3 ± 3.9
4.7 ± 3.0
1.9 ± 1.5
<0.001
 
Hospital stay (days)
mean ± S.D
23.5 ± 11.4
17.6 ± 4.2
13.9 ± 6.9
<0.001
Serology
Preoperative CEA (ng/mL)
≤5
24 (66.7%)
18 (72.0%)
68 (65.4%)
 
  
>5
12 (33.3%)
7 (28.0%)
36 (34.6%)
0.790
 
Postoperative CEA(ng/mL)
≤5
18 (85.7%)
13 (92.9%)
76 (85.4%)
 
  
>5
3 (14.3%)
1 (7.1%)
13 (14.6%)
0.818
ASA, American Society of Anesthesiologists; BMI, Body mass index; CEA, Carcinoembryonic antigen; CTx, Chemotherapy; Cx, Complication; ERHC, Extended right hemicolectomy; H flexure, Hepatic flexure; ICU, Intensive care unit; Lap, Laparoscopic; LN, Lymph node; prox T, Proximal transverse; RH, Right hemicolectomy; TF, Transfusion.
Figure 2a shows the overall survival (OS) rate of all patients in the present study. The mean OS was 156.5 ± 9.6 months. The 5- and 10-year OS rates were 74.1% and 58.9%, respectively. There was no significant difference in OS among the three groups (P = 0.655, Figure 2b). Unfavorable risk factors that influenced OS were advanced stage, deep invasion and lymph node involvement, lymphovascular and perineural invasion, less than 12 lymph nodes retrieval, no adjuvant chemotherapy, reoperation, and higher level of pre- and postoperative CEA. Figure 3a shows the disease-free survival (DFS) rate of all patients in the present study. The mean DFS was 223.4 ± 8.3 months. The 5- and 10-year DFS rates were 79.8% and 77.2%, respectively. There was no significant difference in DFS among the three groups (P = 0.102). However, when DFS between two groups were compared, the DFS rate in group II was lower than that in group I ( P = 0.042) and group III ( P = 0.050) (Figure 3b). Unfavorable factors influencing DFS were advanced stage, deep invasion and lymph node involvement, lymphovascular and perineural invasion, less than 12 lymph nodes retrieval, and higher level of preoperative CEA. In multivariate analysis, lymphatic invasion (P = 0.005 and P < 0.001), venous invasion ( P = 0.001 and P < 0.001), preoperative serum CEA level ( P = 0.031 and P < 0.001), and the retrieval of <12 lymph nodes ( P = 0.031 and P < 0.001) were independent risk factors associated with OS and DFS in stage II and III right-sided colon cancer. Of these, venous invasion was the most potent independent risk factor associated with both OS and DFS (Table 2).
Table 2
Univariate and multivariate analysis for overall survival and disease-free survival in this study
  
Overall survival
Disease-free survival
  
3-yr- (%)
5-yr (%)
10-yr (%)
P value
3-yr (%)
5-yr (%)
10-yr (%)
P value
Univariate
Multivariate
Univariate
Multivariate
Group
I
86.1
82.5
61.1
  
87.5
85.6
81.2
  
 
II
70.3
66.7
59.3
  
66.7
62.9
62.9
  
 
III
77.2
71.2
64.9
0.655
NS
82.8
81.5
81.5
0.102
NS
Location
Cecum
82.1
79.5
63.4
  
84.6
78.6
78.6
  
 
Ascending
79.1
71.9
57.8
  
81.8
80.3
73.9
  
 
Hepatic flexure
77.9
75.6
59.4
  
81.3
81.3
81.3
  
 
Proximal transverse
73.7
66.9
58.6
0.736
NS
78.6
78.6
78.6
0.968
NS
Approach
Open
78.3
73.4
57.5
  
81.6
78.4
75.3
  
 
Lap
79.4
74.8
66.3
0.884
 
82.2
82.2
82.2
0.518
NS§
Vessel ligation
Low ligation
76.9
69.2
55.4
  
69.2
69.2
69.2
  
 
High ligation
78.9
74.1
63.8
0.834
NS
83.1
83.1
83.1
0.185
NS
Stage
II
87.6
81.8
66.6
  
89.1
87.9
83.9
  
 
III
64.8
61.6
45.5
0.004
NS
69.9
66.2
66.2
<0.001
NS
Pathologic T
2
60.0
60.0
60.0
  
60.0
60.0
60.0
  
 
3
82.4
78.2
62.3
  
84.3
82.6
80.5
  
 
4
56.2
45.4
31.1
0.003
NS
67.3
60.6
52.9
0.015
NS
Pathologic N
0
87.3
81.3
66.9
  
89.6
88.3
84.1
  
 
1
72.4
70.1
48.2
  
80.9
80.9
80.9
  
 
2
55.2
50.6
43.4
0.008
NS
53.1
44.6
44.6
<0.001
NS
Differentiation
Well
85.2
79.5
68.5
  
88.4
84.4
80.7
  
 
Moderately
79.9
75.1
50.8
  
83.3
83.3
83.3
  
 
Poorly
60.9
56.2
45.4
  
65.9
59.9
53.9
  
 
Mucinous
72.7
72.7
60.6
0.091
NS
66.7
66.7
66.7
0.025
NS
Lymphatic invasion
No
83.9
79.6
63.6
  
87.4
87.4
87.4
  
 
Yes
64.2
59.7
45.3
0.004
0.005
65.4
63.2
63.2
<0.001
<0.001
Venous invasion
No
79.7
75.1
58.4
  
83.6
82.8
82.8
  
 
Yes
25.0
25.0
25.0
<0.001
0.001
12.5
12.5
12.5
<0.001
<0.001
Perineural invasion
No
80.5
77.1
59.1
  
82.9
82.9
82.9
  
 
Yes
56.5
46.3
46.3
0.029
NS
62.2
55.9
55.9
0.006
NS
Lymph node retrieval
<12
58.3
52.5
45.9
  
62.8
62.8
62.8
  
 
≥12
83.3
78.8
62.3
0.012
0.031
85.9
83.4
80.5
0.002
<0.001
Adjuvant CTx
No
69.7
62.1
36.5
  
82.6
82.6
82.6
  
 
Yes
80.3
76.1
65.1
0.008
NS
81.4
79.0
75.9
0.621
NS
Reoperation
No
79.4
74.5
60.1
  
82.1
79.9
77.4
  
 
Yes
50.0
50.0
25.0
0.041
NS
75.0
75.0
75.0
0.463
NS
Preoperative CEA
≤5
89.1
83.5
68.1
  
89.8
87.5
82.3
  
 
>5
64.7
62.5
49.1
0.003
0.031
68.2
65.2
65.2
<0.001
<0.001
Postoperative CEA
≤5
83.1
77.8
65.1
  
82.8
80.0
75.8
  
 
>5
52.9
52.9
52.9
0.018
NS
64.2
64.2
64.2
0.051
NS
CEA, Carcinoembryonic antigen; CTx, Chemotherapy; NS, Not significant.
For identifying the safety of laparoscopic surgery, in groups II and III oncological outcome was compared between the open and laparoscopic surgery groups. In group II, comparison between the laparoscopic surgery group and the open surgery group showed no difference in OS (P = 0.731) and DFS ( P = 0.677) was observed (Figure 4a and Figure 4b). However, in group III, although not significant statistically, the laparoscopic surgery group had a tendency to provide better long-term OS (P = 0.204) and DFS ( P = 0.236) than the open surgery group (Figure 4c d).
Table 3 shows the univariate and multivariate analysis for risk factors of local recurrence in our series. All local recurrences in our series occurred within 60 months after surgery for primary lesion. Since the application of the laparoscopic approach for right-sided colon cancer surgery, the incidence of local recurrence decreased (P = 0.013). The incidence of local recurrence was significantly lower in patients who underwent high vessel ligation ( P = 0.032) and the retrieval of more than 12 lymph nodes ( P = 0.044). Also, poorly differentiated tumor ( P = 0.042) and venous invasion ( P = 0.049) were worse prognostic factors for local recurrence. In multivariate analysis, the level of vessel ligation (the range of lymph node dissection) was the only independent risk factor for local recurrence.
Table 3
Analysis for risk factor of local recurrence in this study
  
No ( n  = 188)
Yes ( n  = 12)
Univariate
Multivariate
P value
P value
Group
I
51 (87.9%)
7 (12.1%)
  
 
II
25 (92.6%)
2 (7.4%)
  
 
III
112 (97.4%)
3 (2.6%)
0.013
0.304
Location
Cecum
36 (90.0%)
4 (10.0%)
  
 
Ascending
87 (95.6%)
4 (4.4%)
  
 
Hepatic flexure
47 (94.0%)
3 (6.0%)
  
 
Proximal transverse
18 (94.7%)
1 (5.3%)
0.525
 
Approach
Open
98 (91.6%)
9 (8.4%)
  
 
Lap
90 (96.8%
3 (3.2%)
0.146
 
Vessel ligation
Low ligation
11 (84.6%)
2 (15.4%)
  
 
High ligation
130 (97%)
4 (3.0%)
0.032
0.019
Stage
II
117 (95.9%)
5 (4.1%)
  
 
III
70 (90.9%)
7 (9.1%)
0.220
 
Pathologic T
2
5 (100%)
0
  
 
3
162 (94.7%)
9 (5.3%)
  
 
4
20 (87.0%)
3 (13.0%)
0.118
 
Pathologic N
0
113 (95.8%)
5 (4.2%)
  
 
1
46 (90.2%)
5 (9.8%)
  
 
2
28 (93.3%)
2 (6.7%)
0.355
 
Differentiation
Well
53 (98.1%)
1 (1.9%)
  
 
Moderately
104 (94.5%)
6 (5.5%)
  
 
Poorly
19 (82.6%)
4 (17.4%)
  
 
Mucinous
11 (91.7%)
1 (8.3%)
0.042
0.571
Lymphatic invasion
No
108 (95.6%)
5 (4.4%)
  
 
Yes
50 (94.3%)
3 (5.7%)
0.711
 
Venous invasion
No
152 (96.2%)
6 (3.8%)
  
 
Yes
6 (75.0%)
2 (25.0%)
0.049
0.643
Perineural invasion
No
137 (95.1%)
7 (4.9%)
  
 
Yes
22 (95.7%)
1 (4.3%)
0.915
 
Lymph node retrieval
<12
31 (86.1%)
5 (13.9%)
  
 
≥12
156 (95.7%)
7 (4.3%)
0.044
0.995
Adjuvant CTx
No
31 (93.9%)
2 (6.1%)
  
 
Yes
154 (93.9%)
10 (6.1%)
0.994
 
Reoperation
No
184 (93.9%)
12 (6.1%)
  
 
Yes
4 (100%)
0
0.611
 
Preoperative CEA
≤5
105 (95.5%)
5 (2.5%)
  
 
>5
51 (92.7%)
4 (7.3%)
0.483
 
Postoperative CEA
≤5
102 (95.3%)
5 (4.7%)
  
 
>5
16 (94.1%)
1 (5.9%)
0.595
 
CEA, Carcinoembryonic antigen; CTx, Chemotherapy.

Discussion

Laparoscopic colon resection has advantages over open resection in terms of improved early surgical outcomes, including less need for analgesia, earlier resumption of eating, shorter length of hospital stay, and lower rate of postoperative morbidity [68]. However, in cancer surgery, the long-term oncological outcomes appear to be more important than perioperative outcomes. It has been shown in several prospective randomized controlled trials that the long term oncological outcome of laparoscopic surgery in colon cancer is not inferior to that of open surgery [4, 5, 8]. Yet, many institutions still contemplate whether or not to standardize laparoscopic surgery for colon cancer. This may be due to the steep LC posing as a major challenge for surgeons with also the fear that the LC will jeopardize the oncological outcome during the time needed to polish their craft [9, 10].
In respect of long-term oncological outcome, prognostic factors are divided into two categories: factors related to the tumor itself; and factors relating to the surgical procedure. Factors related to the tumor itself are depth of invasion, lymph node metastasis, tumor differentiation, lymphovascular invasion, and preoperative serum CEA level. Factors related to the surgical procedure are adequate resection margin, radical lymphadenectomy, and adequate lymph node harvest. Perioperative complications and failure of successful laparoscopic procedure such as conversion are also factors related to the surgical procedure. In our study, within the factors related to the tumor, we observed that lymphatic invasion (P = 0.005 and P < 0.001), venous invasion ( P = 0.001 and P < 0.001), and preoperative serum CEA level ( P = 0.031 and P < 0.001) were independent risk factors associated with OS and DFS in stage II and III right-sided colon cancer. For patients with above poor prognostic factors, adjuvant therapy such as chemotherapy may be helpful to improve long-term oncological outcomes. Within the factors related to the surgical procedure, adequate lymph node harvest was the only independent prognostic factor related to the surgical procedure ( P = 0.031 and P < 0.001) in both OS and DFS.
The number of harvested lymph nodes may be related to not only the knowledge of anatomy and the experience of surgeon but also the accurate pathologic reporting system. The number of examined lymph nodes itself has prognostic value in predicting outcome. The survival of patients with stage II and III colon cancer has increased with the increased number of lymph nodes examined [11]. In the present study, adequate lymph node harvest was the factor in measuring the LC therefore inadequate lymph node harvest was more frequently found in group II (37.0%) than in group I (6.9%) or group III (19.3%) (Table 1). These differences in nodal counts may have risen from inadequate lymphadenectomy by a surgeon during the LC period. Also, the DFS rate in group II was worse than in group I and III (P = 0.042 and P = 0.050, respectively) (Figure 3b). It remains to be seen whether differences in nodal counts among the three groups are clinically meaningful but from the data gathered the LC period with fewer lymph nodes retrieved seems to correlate with low DFS rate.
Ptock et al. [12] demonstrated that conversion of laparoscopic colon cancer resection worsens DFS in locally advanced stage II carcinoma. They especially emphasized the effect of experience of a surgeon on a successful laparoscopic colon cancer resection. A few recent studies showed that postoperative complication such as anastomotic leakage was associated with poor survival [1315]. Tsuchiya et al. [16] demonstrated that factors such as excessive bleeding, lengthening of operation time, and an increase of surgical manipulation would clearly induce surgical stress. They suggested that several responses induced by surgical stress, such as neuroendocrine responses, cytokine responses, metabolic responses, and other yet unknown biologic responses, may result in a marked enhancement of tumor metastasis by affecting residual or circulating cancer cells or normal host cells in the target organ or tissue of metastasis. In the period of the LC, the condition induced to increase the surgical stress such as conversion or perioperative complication may contribute to DFS negatively. Also, considering the immunological effect, longer operation time in group II may affect DFS negatively [17, 18]. Kang et al. [19] demonstrated that technical difficulty during laparoscopy-assisted surgery jeopardizes oncological safety. They insisted that for oncological safety following laparoscopic assisted surgery, technical difficulty and the number of procedures performed should be considered to evaluate the learning process for a laparoscopic surgeon. In the early period of our laparoscopic series, we experienced many technical difficulties. These technical difficulties resulting from inexperience also may have affected DFS negatively. Lessening of these risk factors related to surgical procedure may be conceivably possible by the endeavor of the surgeons.In the LC period, although surgeons tried to maintain the oncological principle, the no-touch isolation technique fell short in some surgeries, and factors such as conversion rate, operation time, and perioperative complications increased in others [9, 10, 20]. These factors may all have contributed to the increase in surgical stress but despite these setbacks, through perseverance and exploration of numerous techniques, we managed to standardize right-sided colon cancer surgery using the laparoscopic approach. Firstly, right colic mesentery was lifted from the retro-peritoneum without touching the colon itself, focusing on dissecting the mesentery with the diseased colon. For right colectomy, the ileocolic artery and vein, the right-sided branch of the midcolic artery and vein, and the right colic artery and vein if present were skeletonized from their original sites. They were clipped three times at their original sites and cut between the distal second and third clip. This allowed the diseased colon and mesentery to be successfully isolated from the superior mesenteric artery and vein without injuring or touching other parts of the colon. Hence, high vessel ligation (D3 lymph node dissection) was more frequently performed after the introduction of laparoscopic surgery (Table 1). This division prior to tumor-containing bowel mobilization could minimize cancer cell spread though the draining vessels. The medial to lateral approach may be more aligned with the no-touch principle than the lateral to medial approach. Recently, some reports demonstrated that progress in laparoscopic techniques for colorectal cancer surgery has resulted in the development of a medial to lateral approach for D3 lymphadenectomy [21, 22]. Compared with the classical lateral to medial approach, D3 lymphadenectomy using the medial to lateral has the advantage of abiding by the no-touch isolation technique for oncologic surgery [21]. Since Turnbull et al.[23] described the advantage of the no-touch isolation technique for cancer surgery, many reports demonstrated better oncological outcome with this technique [2426]. Hayashi et al. [26] demonstrated that the no-touch isolation technique could prevent cancer cells from being shed into the portal circulation during surgical manipulation. Although exact statistical value was not measured, approach for lymphadenectomy had been mixed to ‘lateral to medial approach’ and ‘medial to lateral approach’ in group I due to different policies amongst several surgeons. Since laparoscopic surgery was introduced, medial to lateral approach became the standard procedure for D3 lymphadenectomy in open as well as laparoscopic colorectal cancer surgery in our institution. In the present study, with gradually increased high vessel ligation, the local recurrence rate decreased gradually in open as well as in laparoscopic surgery after the introduction of laparoscopic surgery (P = 0.013). Also, in multivariate analysis, we found that high vessel ligation was the only independent prognostic factor for local recurrence ( P = 0.019) (Table 3). This finding appears to result from the endeavor of standardizing the surgical procedure, including the accomplishment of D3 lymphadenectomy through high vessel ligation and the medial to lateral approach whilst experiencing the LC in laparoscopic surgery. With the tendency of better long-term oncological outcome of laparoscopic surgery shown in Figure 4, this finding may be considered as the advantage of laparoscopic surgery through the standardization of the technique.
In our study, two surgeons performed laparoscopic surgery. The main surgeon, a pioneer in laparoscopic abdominal surgery in Korea, began performing laparoscopic right sided colon cancer surgery in April 1995. Another surgeon, a junior surgeon, who had experienced laparoscopic surgery as a scope operator for main surgeon’s laparoscopic procedure beginning in March 2001, began laparoscopic right sided colon cancer surgery in April 2004. The LC was based on the results of the main surgeon alone as the corresponding author, (J-G Kim) specializing in colorectal surgery, performed most of the right sided colon cancer surgeries. Although it is unpublished data, we could observe that the LC of the junior surgeon did not have an influence on the oncological outcome. This was because the junior surgeon began his laparoscopic procedure under supervision of a pioneer surgeon after the standardization of the procedure was complete. As shown in Figure 4 and Table 3, long-term oncological outcomes of laparoscopic surgery group in group II are not inferior to the open surgery group. In group III, long-term oncological outcomes of laparoscopic surgery group showed better outcome than the open surgery group. Some reports suggested that the standardization of the colorectal cancer surgery would result in not only the reduction of the LC period but also in lowering recurrence rate and better OS [10, 27]. In our study, while the procedure during the LC resulted in the negative effect on DFS, we observed that once the standardization of the procedure was complete laparoscopic surgery had a tendency to provide reduction in recurrence rate and improved long term oncological outcome compared to open surgery.
Our study has limitations in that it was a retrospective study using the medical records of patients, and the follow-up observation could not be performed in all patients. However, while most reports for the LC of laparoscopic surgery suggested perioperative short-term outcomes as factors for measuring the LC of laparoscopic surgery, our study found that surgical and pathological factors must be considered to measure the LC for cancer surgery.

Conclusions

The laparoscopic approach for stage II and III right-sided colon cancer is safe and feasible in both oncological and technical aspects. However, because of the probability of poor oncological outcomes during the LC period, surgeons must make great efforts to shorten this time frame. Institutions should standardize their techniques and then provide fellowship training for newcomers of laparoscopic colon cancer surgery as this technique once mastered will become the gold standard approach to colon surgery.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The manuscript is an original work and has not been submitted or is under consideration for publication in another journal. The study complies with current ethical consideration. We also confirm that all the listed authors have participated actively in the study, and have seen and approved the submitted manuscript. The authors do not have any possible conflicts of interest. No competing financial interests exist.

Authors’ contributions

K and JGK conceived and designed the study; K, C, HJK, L, S, JGK, and C acquired the data; K, C, HJK, L, S, JGK, and C analyzed and interpreted the data; K, HJK, JGK, and C drafted the manuscript; K, C, HJK, JGK, S, L, and C critically revised the manuscript; K, C, HJK, L, S, JGK, and C approved the final manuscript. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Jacobs M, Verdeja JC, Goldstein HS: Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc. 1991, 1: 144-150.PubMed Jacobs M, Verdeja JC, Goldstein HS: Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc. 1991, 1: 144-150.PubMed
2.
Zurück zum Zitat Sample CB, Watson M, Okrainec A, Gupta R, Birch D, Anvari M: Long-term outcomes of laparoscopic surgery for colorectal cancer. Surg Endosc. 2006, 20: 30-34. 10.1007/s00464-005-0253-z.CrossRefPubMed Sample CB, Watson M, Okrainec A, Gupta R, Birch D, Anvari M: Long-term outcomes of laparoscopic surgery for colorectal cancer. Surg Endosc. 2006, 20: 30-34. 10.1007/s00464-005-0253-z.CrossRefPubMed
3.
Zurück zum Zitat Lezoche E, Guerrieri M, De Sanctis A, Campagnacci R, Baldarelli M, Lezoche G, Paganini AM: Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years. Surg Endosc. 2006, 20: 546--553. 10.1007/s00464-005-0338-8.CrossRefPubMed Lezoche E, Guerrieri M, De Sanctis A, Campagnacci R, Baldarelli M, Lezoche G, Paganini AM: Long-term results of laparoscopic versus open colorectal resections for cancer in 235 patients with a minimum follow-up of 5 years. Surg Endosc. 2006, 20: 546--553. 10.1007/s00464-005-0338-8.CrossRefPubMed
4.
Zurück zum Zitat Liang JT, Huang KC, Lai HS, Lee PH, Jeng YM: Oncologic results of laparoscopic versus conventional open surgery for stage II and III left-sided colon cancers: a randomized controlled trial. Ann Surg Oncol. 2007, 14: 109-117.CrossRefPubMed Liang JT, Huang KC, Lai HS, Lee PH, Jeng YM: Oncologic results of laparoscopic versus conventional open surgery for stage II and III left-sided colon cancers: a randomized controlled trial. Ann Surg Oncol. 2007, 14: 109-117.CrossRefPubMed
5.
Zurück zum Zitat Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, Pahlman L, Cuesta MA, Msika S, Morino M, Lacy A, Bonjer HJ, Colon cancer Laparosocpic or Open Resection sStudy gGroup: Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomized clinical trial. Lancet Oncol. 2009, 10: 44-52.CrossRefPubMed Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Haglind E, Pahlman L, Cuesta MA, Msika S, Morino M, Lacy A, Bonjer HJ, Colon cancer Laparosocpic or Open Resection sStudy gGroup: Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomized clinical trial. Lancet Oncol. 2009, 10: 44-52.CrossRefPubMed
6.
Zurück zum Zitat Guller U, Jain N, Hervey S, Purves H, Pietrobon R: Laparoscopic versus open colectomy: outcomes comparison based on large nationwide databases. Arch Surg. 2003, 138: 1179-1186. 10.1001/archsurg.138.11.1179.CrossRefPubMed Guller U, Jain N, Hervey S, Purves H, Pietrobon R: Laparoscopic versus open colectomy: outcomes comparison based on large nationwide databases. Arch Surg. 2003, 138: 1179-1186. 10.1001/archsurg.138.11.1179.CrossRefPubMed
7.
Zurück zum Zitat Gibson M, Byrd C, Pierce C, Wright F, Norwood W, Gibson T, Zibari GB: Laparoscopic colon resections: a five-year retrospective review. Am Surg. 2000, 66: 245-249.PubMed Gibson M, Byrd C, Pierce C, Wright F, Norwood W, Gibson T, Zibari GB: Laparoscopic colon resections: a five-year retrospective review. Am Surg. 2000, 66: 245-249.PubMed
8.
Zurück zum Zitat The Clinical Outcomes of Surgical Therapy Study Group: A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004, 350: 2050-2059.CrossRef The Clinical Outcomes of Surgical Therapy Study Group: A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004, 350: 2050-2059.CrossRef
9.
Zurück zum Zitat Schlachta CM, Mamazza J, Seshadri PA, Cadeddu M, Gregoire R, Poulin EC: Defining a learning curve for laparoscopic colorectal resections. Dis Colon Rectum. 2001, 44: 217-222. 10.1007/BF02234296.CrossRefPubMed Schlachta CM, Mamazza J, Seshadri PA, Cadeddu M, Gregoire R, Poulin EC: Defining a learning curve for laparoscopic colorectal resections. Dis Colon Rectum. 2001, 44: 217-222. 10.1007/BF02234296.CrossRefPubMed
10.
Zurück zum Zitat Akiyoshi T, Kuroyanagi H, Ueno M, Oya M, Fujimoto Y, Konishi T, Yamaguchi T: Learning curve for standardized laparoscopic surgery for colorectal cancer under supervision: a single-center experience. Surg Endosc. 2011, 25: 1409-1414. 10.1007/s00464-010-1404-4.CrossRefPubMed Akiyoshi T, Kuroyanagi H, Ueno M, Oya M, Fujimoto Y, Konishi T, Yamaguchi T: Learning curve for standardized laparoscopic surgery for colorectal cancer under supervision: a single-center experience. Surg Endosc. 2011, 25: 1409-1414. 10.1007/s00464-010-1404-4.CrossRefPubMed
11.
Zurück zum Zitat Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O’Callaghan CJ, Francini G, Grothey A, O’Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A: Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005, 23: 8664-8670. 10.1200/JCO.2005.01.6071.CrossRefPubMed Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O’Callaghan CJ, Francini G, Grothey A, O’Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A: Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005, 23: 8664-8670. 10.1200/JCO.2005.01.6071.CrossRefPubMed
12.
Zurück zum Zitat Ptok H, Kube R, Schmidt U, Kockerling F, Gastinger I, Lippert H, Colon/Rectum Carcinoma (Primary Tumor); Study Group: Conversion from laparoscopic to open colonic cancer resection - associated factors and their influence on long-term oncological outcome. Eur J Surg Oncol. 2009, 35: 1273-1279. 10.1016/j.ejso.2009.06.006.CrossRefPubMed Ptok H, Kube R, Schmidt U, Kockerling F, Gastinger I, Lippert H, Colon/Rectum Carcinoma (Primary Tumor); Study Group: Conversion from laparoscopic to open colonic cancer resection - associated factors and their influence on long-term oncological outcome. Eur J Surg Oncol. 2009, 35: 1273-1279. 10.1016/j.ejso.2009.06.006.CrossRefPubMed
13.
Zurück zum Zitat Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, Bokey EL: Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg. 2004, 240: 255-259. 10.1097/01.sla.0000133186.81222.08.PubMedCentralCrossRefPubMed Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, Bokey EL: Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg. 2004, 240: 255-259. 10.1097/01.sla.0000133186.81222.08.PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat McArdle Cs, McMillan DC, Hole DJ: Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg. 2005, 92: 1150-1154. 10.1002/bjs.5054.CrossRefPubMed McArdle Cs, McMillan DC, Hole DJ: Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg. 2005, 92: 1150-1154. 10.1002/bjs.5054.CrossRefPubMed
15.
Zurück zum Zitat Law WL, Choi HK, Lee YM, Ho JWC, Seto CL: Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg. 2007, 11: 8-15. 10.1007/s11605-006-0049-z.CrossRefPubMed Law WL, Choi HK, Lee YM, Ho JWC, Seto CL: Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg. 2007, 11: 8-15. 10.1007/s11605-006-0049-z.CrossRefPubMed
16.
Zurück zum Zitat Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, Tsukada K, Saiki I: Increased surgical stress promotes tumor metastasis. Surgery. 2003, 133: 547-555. 10.1067/msy.2003.141.CrossRefPubMed Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, Tsukada K, Saiki I: Increased surgical stress promotes tumor metastasis. Surgery. 2003, 133: 547-555. 10.1067/msy.2003.141.CrossRefPubMed
17.
Zurück zum Zitat Lacy AM, Carcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, Visa J: Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomized trial. Lancet. 2002, 359: 2224-2229. 10.1016/S0140-6736(02)09290-5.CrossRefPubMed Lacy AM, Carcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, Visa J: Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomized trial. Lancet. 2002, 359: 2224-2229. 10.1016/S0140-6736(02)09290-5.CrossRefPubMed
18.
Zurück zum Zitat Baca I, Perko Z, Bokan I, Mimica Z, Petricevic A, Druzijanic N, Situm M: Technique and survival after laparoscopically assisted right hemicolectomy. Surg Endosc. 2005, 19: 650-655. 10.1007/s00464-004-9068-6.CrossRefPubMed Baca I, Perko Z, Bokan I, Mimica Z, Petricevic A, Druzijanic N, Situm M: Technique and survival after laparoscopically assisted right hemicolectomy. Surg Endosc. 2005, 19: 650-655. 10.1007/s00464-004-9068-6.CrossRefPubMed
19.
Zurück zum Zitat Kang SB, Park JS, Kim DW, Lee TG: Intraoperative technical difficulty during laparoscopy-assisted surgery as a prognostic factor for colorectal cancer. Dis Colon Rectum. 2010, 53: 1400-1408. 10.1007/DCR.0b013e3181e5e0b1.CrossRefPubMed Kang SB, Park JS, Kim DW, Lee TG: Intraoperative technical difficulty during laparoscopy-assisted surgery as a prognostic factor for colorectal cancer. Dis Colon Rectum. 2010, 53: 1400-1408. 10.1007/DCR.0b013e3181e5e0b1.CrossRefPubMed
20.
Zurück zum Zitat Tekkis PP, Senagore AJ, Delaney CP, Fazio VW: Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg. 2005, 242: 83-91. 10.1097/01.sla.0000167857.14690.68.PubMedCentralCrossRefPubMed Tekkis PP, Senagore AJ, Delaney CP, Fazio VW: Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resections. Ann Surg. 2005, 242: 83-91. 10.1097/01.sla.0000167857.14690.68.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Lee SD, Lim SB: D3 lymphadenectomy using a medial to lateral approach for curable right-sided colon cancer. Int J Colorectal Dis. 2009, 24: 295-300. 10.1007/s00384-008-0597-7.CrossRefPubMed Lee SD, Lim SB: D3 lymphadenectomy using a medial to lateral approach for curable right-sided colon cancer. Int J Colorectal Dis. 2009, 24: 295-300. 10.1007/s00384-008-0597-7.CrossRefPubMed
22.
Zurück zum Zitat Liang JT, Lai HS, Lee PH: Laparoscopic medial-to-lateral approach for the curative resection of right-sided colon cancer. Ann Surg Oncol. 2007, 14: 1878-1879. 10.1245/s10434-006-9153-2.CrossRefPubMed Liang JT, Lai HS, Lee PH: Laparoscopic medial-to-lateral approach for the curative resection of right-sided colon cancer. Ann Surg Oncol. 2007, 14: 1878-1879. 10.1245/s10434-006-9153-2.CrossRefPubMed
23.
Zurück zum Zitat Turnbull RB, Kyle K, Watson FU, Spratt J: Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967, 166: 420-427. 10.1097/00000658-196709000-00010.PubMedCentralCrossRefPubMed Turnbull RB, Kyle K, Watson FU, Spratt J: Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967, 166: 420-427. 10.1097/00000658-196709000-00010.PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Turnbull RB: Cancer of the colon. The five- and ten-year survival rates following resection utilizing the isolation technique. Ann R Coll Surg Engl. 1970, 46: 243-350.PubMedCentralPubMed Turnbull RB: Cancer of the colon. The five- and ten-year survival rates following resection utilizing the isolation technique. Ann R Coll Surg Engl. 1970, 46: 243-350.PubMedCentralPubMed
25.
Zurück zum Zitat Wiggers T, Jeekel J, Arends JW, Brinkhorst AP, Kluck HM, Luyk CI, Munting JD, Povel JA, Rutten AP, Volovics A, Greep JM: No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg. 1988, 75: 409-415. 10.1002/bjs.1800750505.CrossRefPubMed Wiggers T, Jeekel J, Arends JW, Brinkhorst AP, Kluck HM, Luyk CI, Munting JD, Povel JA, Rutten AP, Volovics A, Greep JM: No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg. 1988, 75: 409-415. 10.1002/bjs.1800750505.CrossRefPubMed
26.
Zurück zum Zitat Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M: No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery. 1999, 125: 369-374. 10.1016/S0039-6060(99)70003-6.CrossRefPubMed Hayashi N, Egami H, Kai M, Kurusu Y, Takano S, Ogawa M: No-touch isolation technique reduces intraoperative shedding of tumor cells into the portal vein during resection of colorectal cancer. Surgery. 1999, 125: 369-374. 10.1016/S0039-6060(99)70003-6.CrossRefPubMed
27.
Zurück zum Zitat Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S: Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome. Colorectal Dis. 2009, 11: 354-365. 10.1111/j.1463-1318.2008.01735.x.CrossRefPubMed Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S: Standardized surgery for colonic cancer: complete mesocolic excision and central ligation - technical notes and outcome. Colorectal Dis. 2009, 11: 354-365. 10.1111/j.1463-1318.2008.01735.x.CrossRefPubMed
Metadaten
Titel
The effect of laparoscopic surgery in stage II and III right-sided colon cancer: a retrospective study
verfasst von
Bong-Hyeon Kye
Jun-Gi Kim
Hyeon-Min Cho
Jung Hwan Lee
Hyung-Jin Kim
Young-Jin Suh
Chung-Soo Chun
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2012
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-89

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgical Oncology 1/2012 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.